Human immunodeficiency virus type 1 particles pseudotyped with envelope proteins that fuse at low pH no longer require Nef for optimal infectivity

Journal of Virology

Volumn 75, Issue 8, 2001, Pages 4014-4018

  Chazal, N ^a   Singer, G ^a   Aiken, C ^a   Hammarskjold M L ^a   Rekosh, D ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; ENVELOPE PROTEIN; GLYCOPROTEIN; NEF PROTEIN; VIRUS PROTEIN;

ARTICLE; EBOLA VIRUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FUSION GENE; GENE CONSTRUCT; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; NUCLEOTIDE SEQUENCE; PH; PRIORITY JOURNAL; VESICULAR STOMATITIS VIRUS; VIRUS INFECTION; VIRUS PARTICLE; VIRUS VIRULENCE;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIBODIES, VIRAL; CELL LINE; GENE DELETION; GENE PRODUCTS, NEF; HELA CELLS; HIV ENVELOPE PROTEIN GP120; HIV-1; HUMANS; HYDROGEN-ION CONCENTRATION; IMMUNE SERA; MACROLIDES; MEMBRANE FUSION; MEMBRANE GLYCOPROTEINS; MOLECULAR SEQUENCE DATA; NEUTRALIZATION TESTS; RECEPTORS, HIV; VIRAL ENVELOPE PROTEINS;

EID: 0035088135     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.8.4014-4018.2001     Document Type: Article

References (39)

1. Pseudotyping human immunodeficiency virus type 1 (HIV-1) by the glycoprotein of vesicular stomatitis virus targets HIV-1 entry to an endocytic pathway and suppresses both the requirement for Nef and the sensitivity to cyclosporin A
2. Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis
3. Chemokine receptors and HIV-1: An attractive pair?
4. Bafilomycins: A class of inhibitors of membrane ATPases from microorganisms, animal cells, and plant cells
5. Nef association with human immunodeficiency virus type 1 virions and cleavage by the viral protease
6. A CD4 domain important for HIV-mediated syncytium formation lies outside the virus binding site
7. Distinct mechanisms of entry by envelope glycoproteins of Marburg and Ebola (Zaire) viruses
8. The growth advantage conferred by HIV-1 nef is determined at the level of viral DNA formation and is independent of CD4 downregulation
9. Optimal infectivity in vitro of human immunodeficiency virus type 1 requires an intact nef gene
10. Identification of a major co-receptor for primary isolates of HIV-1
11. Endocytic entry of HIV-1
12. HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor
13. New host cell system for regulated simian virus 40 DNA replication
14. HIV: Early virus-cell interactions
15. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene
16. Association of Nef with the human immunodeficiency virus type 1 core
17. Pseudotyping with human T-cell leukemia virus type 1 broadens the human immunodeficiency virus host range
18. Identification of a cis-acting element in human immunodeficiency virus type 2 (HIV-2) that is responsive to the HIV-1 rev and human T-cell leukemia virus type I and II rex proteins
19. Infectivity enhancement by HIV-1 Nef is dependent on the pathway of virus entry: Implications for HIV-based gene transfer systems
20. SFV infection in CHO cells: Cell-type specific restrictions to productive virus entry at the cell surface
21. Pathway of vesicular stomatitis virus entry leading to infection
22. The pH independence of mammalian retrovirus infection
23. The HIV-1 nef gene acts as a positive viral infectivity factor
24. The human immunodeficiency virus-1 nef gene product: A positive factor for viral infection and replication in primary lymphocytes and macrophages
25. Expression of the human immunodeficiency virus type 1 (HIV-1) nef gene during HIV-1 production increases progeny particle infectivity independently of gp.160 or viral entry
26. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector
27. Producer-cell modification of human immunodeficiency virus type 1: Nef is a virion protein
28. Human immunodeficiency virus infection of T cells and monocytes proceeds via receptor-mediated endocytosis
29. Simian immunodeficiency virus RNA is efficiently encapsidated by human immunodeficiency virus type 1 particles
30. Human immunodeficiency virus type 1 Nef increases the efficiency of reverse transcription in the infected cell
31. The effect of viral regulatory protein expression on gene delivery by human immunodeficiency virus type 1 vectors produced in stable packaging cell lines
32. pH-independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membrane
33. The cytotoxic action of diphtheria toxin and its degradation in intact Vero cells are inhibited by bafilomycin A1, a specific inhibitor of vacuolar-type H(+)-ATPase
34. Human immunodeficiency virus type 1 Nef protein is incorporated into virus particles specifically cleaved by the viral proteinase
35. Characterization of Ebola virus entry by using pseudotyped viruses: Identification of receptor-deficient cell lines
36. Immunization for Ebola virus infection
37. Vesicular stomatitis virus binds and fuses with phospholipid domain in target cell membranes
38. Distinct cellular interactions of secreted and transmembrane Ebola virus glycoproteins
39. Bafilomycin A1, a specific inhibitor of vacuolar-type H(+)-ATPase, inhibits acidification and protein degradation in lysosomes of cultured cells